NDGA, a non-selective inhibitor of the LOX pathway, contributes to increased apoptosis in different cell lines including neuroblastoma [22], gastrointestinal cancer [2], as well as suppresses migration and metastasis of prostate cancer cells [23]. Here, LOX is linked to prostate carcinoma.